Claire McCaskill said...
Letter from Senator Claire McCaskill to Santosh Vetticaden, Interim Chief Executive Officer of Insys Therapeutics, Inc. (March 28, 2017).
Context
McCaskill addressed concerns regarding opioid manufacturers and advocacy groups.
03/27/2017